Replies to post #49957 on Ariad Pharmaceuticals Inc fka ARIA

[micanwait]

Denner of course understands that the IDIX windfall for his investment group was a result of a bidding war (in which I assume he played a role).


"Biotech this morning is doing well due to Merck's (NYSE:MRK) bid for Idenix Pharmaceuticals (NASDAQ:IDIX) for a hefty premium in a competitive bidding war against (apparently) Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV). Idenix closed at $7.23 on Friday and was bought for $24."

http://www.minyanville.com/special-features/from-the-buzz-banter/articles/Negative-Sentiment-Nearly-Unanimous-Among/6/9/2014/id/55241